Deep brain stimulation of the motor thalamus to improve cortico-spinal control of muscles after stroke
Project Number1R01NS131428-01A1
Former Number1R01NS131428-01
Contact PI/Project LeaderPIRONDINI, ELVIRA Other PIs
Awardee OrganizationUNIVERSITY OF PITTSBURGH AT PITTSBURGH
Description
Abstract Text
SUMMARY
Motivation: Stroke is one of the leading causes of permanent motor disability in the United States, affecting
approximately 795,000 people a year. Despite the large population size of affected individuals, intense physical
therapy remains the only significant intervention with limited impact on moderated to severe paresis. Therefore,
the development of novel and effective therapeutic approaches is necessary for these patients. Neurostimula-
tion, like deep brain stimulation (DBS), is a promising approach that could extend recovery beyond physical
therapy. A possible target for DBS to treat post-stroke motor deficits is the motor thalamus, which is a thalamic
relay with outgoing excitatory connectivity to sensory/motor cortices.
Project Goal: Here we propose to design a new DBS approach targeting the motor thalamus to improve motor
output following stroke. For this, we will perform a mechanistic-driven identification of the optimal target of
stimulation within the motor thalamus and optimization of the stimulation parameters in monkeys.
Hypothesis: we hypothesize that 1) stimulation of specific nuclei of the motor thalamus potentiates motor out-
put by increasing excitability of cortical motoneurons via thalamocortical synaptic excitatory projections; 2) a
restricted set of stimulation parameters enables potentiation of motor output that persists after stroke in anes-
thetized monkeys; and 3) in awake monkeys with chronic stroke improves motor performances.
Approach: We developed the first monkey model of stroke within the internal capsule (IC), a deep white matter
brain structure that hosts the cortico-spinal tract (CST) and that is often damaged after stroke. We will leverage
this model first in anesthetized monkeys to identify optimal stimulation targets and parameters. For this, we will
position a stimulating probe in IC and one in each nucleus of the motor thalamus. We will first establish the
optimal stimulation nucleus by elucidating mechanisms of action of stimulation and by identifying which nucleus
must be stimulated to maximize: 1) cortical evoked potentials (CEPs) in the motor cortex, and 2) motor evoked
potentials (MEPs) triggered by IC or motor cortex stimulation when paired with DBS. We will then compare
MEPs with continuous or burst DBS. We expect that the ventral laterolateral (VLL) nucleus will maximally po-
tentiates MEPs and CEPs when the CST are intact and after a stroke. Finally, we will test the effects of the
optimal stimulation target and parameters during behavioral upper-limb tasks in awake animals with chronic
stroke. We expect that also in this case VLL stimulation will improve strength and motor performances.
Preliminary data: We developed and piloted the necessary techniques: i) we have designed a robot-assisted
neurosurgery approach to lesion the IC without damaging the sensorimotor cortex; ii) we have piloted the ef-
fects of VLL stimulation in anesthetized animals; and iii) we have characterized a chronic model of IC stroke.
Perspective: These pre-clinical monkey data will provide critical evidence to support future human studies
involving implantation of FDA approved leads in the motor thalamus in people with lesions of the CST.
1
Public Health Relevance Statement
PROJECT NARRATIVE
Humans with stroke lesion invading the cortico-spinal tracts (CST) suffer from the most severe
and permanent motor deficits, which include loss of finger dexterity and muscle weakness. Here,
we aim at designing a new deep brain stimulation therapy to treat post-stroke muscle weakness
and motor paresis by targeting the motor thalamus, i.e., a subcortical relay with outgoing
excitatory connectivity to sensory/motor cortices. For this, we will demonstrate that motor
thalamus stimulation increases the excitability of the motor cortex and that these excitatory inputs
can potentiate motor output in intact animals and animals with chronic lesions of the CST both
when anesthetized and during behaving motor tasks.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
004514360
UEI
MKAGLD59JRL1
Project Start Date
15-December-2023
Project End Date
30-November-2028
Budget Start Date
15-December-2023
Budget End Date
30-November-2024
Project Funding Information for 2024
Total Funding
$618,013
Direct Costs
$396,204
Indirect Costs
$221,809
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$618,013
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01NS131428-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01NS131428-01A1
Patents
No Patents information available for 1R01NS131428-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01NS131428-01A1
Clinical Studies
No Clinical Studies information available for 1R01NS131428-01A1
News and More
Related News Releases
No news release information available for 1R01NS131428-01A1
History
No Historical information available for 1R01NS131428-01A1
Similar Projects
No Similar Projects information available for 1R01NS131428-01A1